FDA's designation provides FG-2101 with an additional five years of market exclusivity and priority review SAN DIEGO, Oct. 13, 2025 /PRNewswire/ -- Blacksmith Medicines, Inc. (Blacksmith), a leading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback